{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:19:21Z","timestamp":1788542361693,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000151","name":"Division of Industrial Innovation and Partnerships","doi-asserted-by":"publisher","award":["IIP-2137264"],"award-info":[{"award-number":["IIP-2137264"]}],"id":[{"id":"10.13039\/100000151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purposes<\/jats:title>\n                    <jats:p>The tabletability flip phenomenon (TFP), where an active pharmaceutical ingredient (API) with poorer tabletability exhibits better tabletability when formulated with excipients, has been well documented in direct compression systems. However, the impact of granulation on TFP remains unexplored. Hence, the purpose of this work was to investigate the occurrence and underlying mechanisms of TFP in dry-granulated formulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Acetaminophen (APAP) and ibuprofen (IBU) were used as model APIs since they exhibit TFP in non-granulated blends. Granules of each API were prepared at two porosity levels (9% and 19%) by controlling compaction pressure. Granules with and without varying levels of extragranular magnesium stearate (MgSt) were evaluated for tabletability, bonding area (BA), and bonding strength (BS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>For the more porous granules (19% porosity), extensive fragmentation during compaction preserved TFP through the same mechanism observed in the pre-blends. In contrast, the less porous granules (9% porosity) remained largely unfragmented during compaction, allowing their intrinsic mechanical properties to govern the BA\u2013BS interplay. Although APAP granules showed smaller BA due to lower deformability, the higher BS led to superior tabletability, thus maintaining TFP. The incorporation of\u2009\u2265\u20091% MgSt minimized BS difference between formulations, effectively eliminating TFP, since the softer IBU granules exhibited higher tabletability due to larger BA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These results demonstrated the applicability of the BA\u2013BS framework in explaining TFP in granulated systems and highlight the importance of controlling granule porosity and MgSt levels to optimize tabletability in dry granulation processes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11095-025-04005-z","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:15:53Z","timestamp":1766016953000},"page":"2381-2392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tabletability Flip in Dry Granulated Systems"],"prefix":"10.1007","volume":"43","author":[{"given":"Zijian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-5334","authenticated-orcid":false,"given":"Changquan Calvin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"4005_CR1","doi-asserted-by":"crossref","unstructured":"Augsburger LL, Hoag SW editors. Pharmaceutical Dosage Forms: Tablets. 3rd ed. Boca Raton (FL): CRC Press; 2016.","DOI":"10.1201\/b15115"},{"key":"4005_CR2","unstructured":"Armstrong NA. Tablet Manufacture by Direct Compression. In: Encyclopedia of Pharmaceutical Science and Technology. 4th ed. Boca Raton (FL): CRC Press; 2013."},{"key":"4005_CR3","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.xphs.2017.11.023","volume":"107","author":"S Chattoraj","year":"2018","unstructured":"Chattoraj S, Sun CC. Crystal and particle engineering strategies for improving powder compression and flow properties to enable continuous tablet manufacturing by direct compression. J Pharm Sci. 2018;107:968\u201374. https:\/\/doi.org\/10.1016\/j.xphs.2017.11.023.","journal-title":"J Pharm Sci"},{"key":"4005_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijpharm.2017.03.011","volume":"523","author":"AN Trementozzi","year":"2017","unstructured":"Trementozzi AN, Leung C-Y, Osei-Yeboah F, Irdam E, Lin Y, MacPhee JM, et al. Engineered particles demonstrate improved flow properties at elevated drug loadings for direct compression manufacturing. Int J Pharm. 2017;523:133\u201341. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.011.","journal-title":"Int J Pharm"},{"key":"4005_CR5","doi-asserted-by":"publisher","unstructured":"Ranjan OP, Kumbhar AP. 10 - Dry and wet granulation. In: Parambath A, editor. Polym Oral Drug Deliv Technol [Internet]. Elsevier Science Ltd; 2025 [cited 2025 July 15]. p. 463\u201394. https:\/\/doi.org\/10.1016\/B978-0-443-13774-7.00010-4","DOI":"10.1016\/B978-0-443-13774-7.00010-4"},{"key":"4005_CR6","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1016\/j.xphs.2020.09.005","volume":"109","author":"S Paul","year":"2020","unstructured":"Paul S, Wang C, Sun CC. Tabletability flip \u2013 role of bonding area and bonding strength interplay. J Pharm Sci. 2020;109:3569\u201373. https:\/\/doi.org\/10.1016\/j.xphs.2020.09.005.","journal-title":"J Pharm Sci"},{"key":"4005_CR7","doi-asserted-by":"publisher","first-page":"123262","DOI":"10.1016\/j.ijpharm.2023.123262","volume":"643","author":"Z Wang","year":"2023","unstructured":"Wang Z, Wang C, Bahl D, Sun CC. The ubiquity of the tabletability flip phenomenon. Int J Pharm. 2023;643:123262. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123262.","journal-title":"Int J Pharm"},{"key":"4005_CR8","doi-asserted-by":"publisher","first-page":"125337","DOI":"10.1016\/j.ijpharm.2025.125337","volume":"672","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang C, Sun CC. Elucidating critical factors driving the tabletability flip phenomenon. Int J Pharm. 2025;672:125337. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125337.","journal-title":"Int J Pharm"},{"key":"4005_CR9","doi-asserted-by":"publisher","first-page":"107151","DOI":"10.1016\/j.ejps.2025.107151","volume":"211","author":"VG Bhagali","year":"2025","unstructured":"Bhagali VG, Vreeman G, Hasabnis A, Sun CC. Predicting the tabletability of binary powder mixtures from that of individual components. Eur J Pharm Sci. 2025;211:107151. https:\/\/doi.org\/10.1016\/j.ejps.2025.107151.","journal-title":"Eur J Pharm Sci"},{"key":"4005_CR10","doi-asserted-by":"publisher","first-page":"126340","DOI":"10.1016\/j.ijpharm.2025.126340","volume":"643","author":"Z Wang","year":"2025","unstructured":"Wang Z, Sun CC. Predicting tabletability flip in pharmaceutical powders via a mixture tabletability model. Int J Pharm. 2025;643:126340. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.126340.","journal-title":"Int J Pharm"},{"key":"4005_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1163\/016942410X525678","volume":"25","author":"CC Sun","year":"2011","unstructured":"Sun CC. Decoding powder tabletability: roles of particle adhesion and plasticity. J Adhes Sci Technol. 2011;25:483\u201399. https:\/\/doi.org\/10.1163\/016942410X525678.","journal-title":"J Adhes Sci Technol"},{"key":"4005_CR12","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1021\/acs.molpharmaceut.7b00124","volume":"14","author":"S-Y Chang","year":"2017","unstructured":"Chang S-Y, Sun CC. Superior plasticity and tabletability of theophylline monohydrate. Mol Pharm. 2017;14:2047\u201355. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00124.","journal-title":"Mol Pharm"},{"key":"4005_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S1461-5347(98)00111-4","volume":"2","author":"S Jain","year":"1999","unstructured":"Jain S. Mechanical properties of powders for compaction and tableting: an overview. Pharm Sci Technol Today. 1999;2:20\u201331. https:\/\/doi.org\/10.1016\/S1461-5347(98)00111-4.","journal-title":"Pharm Sci Technol Today"},{"key":"4005_CR14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1208\/s12249-013-0008-4","volume":"14","author":"KS Khomane","year":"2013","unstructured":"Khomane KS, Bansal AK. Effect of particle size on in-die and out-of-die compaction behavior of ranitidine hydrochloride polymorphs. AAPS PharmSciTech. 2013;14:1169\u201377. https:\/\/doi.org\/10.1208\/s12249-013-0008-4.","journal-title":"AAPS PharmSciTech"},{"key":"4005_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.2042-7158.1982.tb04727.x","volume":"34","author":"A Mckenna","year":"1982","unstructured":"Mckenna A, Mccafferty DF. Effect of particle size on the compaction mechanism and tensile strength of tablets. J Pharm Pharmacol. 1982;34:347\u201351. https:\/\/doi.org\/10.1111\/j.2042-7158.1982.tb04727.x.","journal-title":"J Pharm Pharmacol"},{"key":"4005_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0378-5173(02)00296-X","volume":"244","author":"N Rasenack","year":"2002","unstructured":"Rasenack N, M\u00fcller BW. Crystal habit and tableting behavior. Int J Pharm. 2002;244:45\u201357. https:\/\/doi.org\/10.1016\/S0378-5173(02)00296-X.","journal-title":"Int J Pharm"},{"key":"4005_CR17","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3390\/pharmaceutics14091901","volume":"14","author":"Z Wang","year":"2022","unstructured":"Wang Z, Solomos M, Axnanda S, Chen C, Figus M, Schenck L, et al. Varied bulk powder properties of micro-sized API within size specifications as a result of particle engineering methods. Pharmaceutics. 2022;14:1901. https:\/\/doi.org\/10.3390\/pharmaceutics14091901.","journal-title":"Pharmaceutics"},{"key":"4005_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v23.i1.10","volume":"23","author":"S Patel","year":"2006","unstructured":"Patel S, Kaushal A, Bansal A. Compression Physics in the Formulation Development of Tablets. Crit Rev Ther Drug Carrier Syst. 2006;23:1\u201365. https:\/\/doi.org\/10.1615\/CritRevTherDrugCarrierSyst.v23.i1.10.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"4005_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/jps.20262","volume":"94","author":"CK Tye","year":"2005","unstructured":"Tye CK, Sun CC, Amidon GE. Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction. J Pharm Sci. 2005;94:465\u201372. https:\/\/doi.org\/10.1002\/jps.20262.","journal-title":"J Pharm Sci"},{"key":"4005_CR20","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s11095-016-1858-8","volume":"33","author":"F Osei-Yeboah","year":"2016","unstructured":"Osei-Yeboah F, Chang S-Y, Sun CC. A critical examination of the phenomenon of bonding area - bonding strength interplay in powder tableting. Pharm Res. 2016;33:1126\u201332. https:\/\/doi.org\/10.1007\/s11095-016-1858-8.","journal-title":"Pharm Res"},{"key":"4005_CR21","doi-asserted-by":"publisher","first-page":"125172","DOI":"10.1016\/j.ijpharm.2025.125172","volume":"670","author":"C Wu","year":"2025","unstructured":"Wu C, Wang Z, Han X, Yu X, Sun CC, Zhou Z. Simultaneously improving tabletability and solubility of diclofenac by cocrystallization with picolinamide. Int J Pharm. 2025;670:125172. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125172.","journal-title":"Int J Pharm"},{"key":"4005_CR22","doi-asserted-by":"publisher","first-page":"123956","DOI":"10.1016\/j.ijpharm.2024.123956","volume":"654","author":"Z Wang","year":"2024","unstructured":"Wang Z, Wang C, Guo Y, Bahl D, Fok A, Sun CC. A new insight into the mechanism of the tabletability flip phenomenon. Int J Pharm. 2024;654:123956. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.123956.","journal-title":"Int J Pharm"},{"key":"4005_CR23","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1002\/jps.20459","volume":"94","author":"CC Sun","year":"2005","unstructured":"Sun CC. True Density of Microcrystalline Cellulose. J Pharm Sci. 2005;94:2132\u20134. https:\/\/doi.org\/10.1002\/jps.20459.","journal-title":"J Pharm Sci"},{"key":"4005_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/jps.20531","volume":"95","author":"CC Sun","year":"2006","unstructured":"Sun CC, Himmelspach MW. Reduced tabletability of roller compacted granules as a result of granule size enlargement. J Pharm Sci Elsevier. 2006;95:200\u20136. https:\/\/doi.org\/10.1002\/jps.20531.","journal-title":"J Pharm Sci Elsevier"},{"key":"4005_CR25","doi-asserted-by":"publisher","first-page":"124855","DOI":"10.1016\/j.ijpharm.2024.124855","volume":"667","author":"Y Guo","year":"2024","unstructured":"Guo Y, Martinez L, Palanisamy A, Gururajan B, Sun CC. An evaluation of six techniques for measuring porosity of ribbons produced by roller compaction. Int J Pharm. 2024;667:124855. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124855.","journal-title":"Int J Pharm"},{"key":"4005_CR26","doi-asserted-by":"publisher","first-page":"122409","DOI":"10.1016\/j.ijpharm.2022.122409","volume":"629","author":"C Wang","year":"2022","unstructured":"Wang C, Sun CC. A critical examination of three-point bending for determining Young\u2019s modulus. Int J Pharm. 2022;629:122409. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122409.","journal-title":"Int J Pharm"},{"key":"4005_CR27","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/jps.2600590523","volume":"59","author":"JT Fell","year":"1970","unstructured":"Fell JT, Newton JM. Determination of tablet strength by the diametral-compression test. J Pharm Sci. 1970;59:688\u201391. https:\/\/doi.org\/10.1002\/jps.2600590523.","journal-title":"J Pharm Sci"},{"key":"4005_CR28","doi-asserted-by":"publisher","first-page":"117709","DOI":"10.1016\/j.powtec.2022.117709","volume":"408","author":"G Vreeman","year":"2022","unstructured":"Vreeman G, Sun CC. A powder tabletability equation. Powder Technol. 2022;408:117709. https:\/\/doi.org\/10.1016\/j.powtec.2022.117709.","journal-title":"Powder Technol"},{"key":"4005_CR29","first-page":"1001","volume":"221","author":"RW Heckel","year":"1961","unstructured":"Heckel RW. An analysis of powder compaction phenomena. Trans Met Soc AIME. 1961;221:1001\u20138.","journal-title":"Trans Met Soc AIME"},{"key":"4005_CR30","first-page":"671","volume":"221","author":"RW Heckel","year":"1961","unstructured":"Heckel RW. Density-Pressure Relationships in Powder Compaction. Trans Met Soc AIME. 1961;221:671\u20135.","journal-title":"Trans Met Soc AIME"},{"key":"4005_CR31","doi-asserted-by":"publisher","first-page":"100094","DOI":"10.1016\/j.ijpx.2021.100094","volume":"3","author":"G Vreeman","year":"2021","unstructured":"Vreeman G, Sun CC. Mean yield pressure from the in-die Heckel analysis is a reliable plasticity parameter. Int J Pharm: X. 2021;3:100094. https:\/\/doi.org\/10.1016\/j.ijpx.2021.100094.","journal-title":"Int J Pharm: X"},{"key":"4005_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/10837450.2020.1839763","volume":"26","author":"JL Calahan","year":"2021","unstructured":"Calahan JL, Paul S, Yanez EG, DeNeve D, Sun CC, Munson EJ. The impact of solid-state form, water content and surface area of magnesium stearate on lubrication efficiency, tabletability, and dissolution. Pharm Dev Technol Taylor & Francis. 2021;26:150\u20136. https:\/\/doi.org\/10.1080\/10837450.2020.1839763.","journal-title":"Pharm Dev Technol Taylor & Francis"},{"key":"4005_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119927","volume":"590","author":"J Dun","year":"2020","unstructured":"Dun J, Chen H, Sun CC. Profound tabletability deterioration of microcrystalline cellulose by magnesium stearate. Int J Pharm. 2020;590:119927. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119927.","journal-title":"Int J Pharm"},{"key":"4005_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2010.01.007","volume":"75","author":"J Wang","year":"2010","unstructured":"Wang J, Wen H, Desai D. Lubrication in tablet formulations. Eur J Pharm Biopharm. 2010;75:1\u201315. https:\/\/doi.org\/10.1016\/j.ejpb.2010.01.007.","journal-title":"Eur J Pharm Biopharm"},{"key":"4005_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/10837450903095342","volume":"15","author":"JF Gamble","year":"2010","unstructured":"Gamble JF, Tobyn M, Dennis AB, Shah T. Roller compaction: application of an in-gap ribbon porosity calculation for the optimization of downstream granule flow and compactability characteristics. Pharm Dev Technol. 2010;15:223\u20139. https:\/\/doi.org\/10.3109\/10837450903095342.","journal-title":"Pharm Dev Technol"},{"key":"4005_CR36","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.powtec.2018.07.009","volume":"338","author":"W-J Sun","year":"2018","unstructured":"Sun W-J, Rantanen J, Sun CC. Ribbon density and milling parameters that determine fines fraction in a dry granulation. Powder Technol. 2018;338:162\u20137. https:\/\/doi.org\/10.1016\/j.powtec.2018.07.009.","journal-title":"Powder Technol"},{"key":"4005_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijpharm.2007.01.035","volume":"338","author":"MG Herting","year":"2007","unstructured":"Herting MG, Kleinebudde P. Roll compaction\/dry granulation: effect of raw material particle size on granule and tablet properties. Int J Pharm. 2007;338:110\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.01.035.","journal-title":"Int J Pharm"},{"key":"4005_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejpb.2016.04.003","volume":"106","author":"CC Sun","year":"2016","unstructured":"Sun CC, Kleinebudde P. Mini review: mechanisms to the loss of tabletability by dry granulation. Eur J Pharm Biopharm. 2016;106:9\u201314. https:\/\/doi.org\/10.1016\/j.ejpb.2016.04.003.","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-04005-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-025-04005-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-04005-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:08:10Z","timestamp":1788541690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-025-04005-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4005"],"URL":"https:\/\/doi.org\/10.1007\/s11095-025-04005-z","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}